BioNTech SE - ADR vs Payoneer Global Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: BioNTech SE - ADR is far larger — about 9.7× Payoneer Global Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | PAYO | |
|---|---|---|
Market Cap | $23.31B | $2.40B |
Sector | Health | Technology |
52-Week High | $119.34 | $7.17 |
52-Week Low | $83.89 | $4.27 |
Enterprise Value | $6.60B | $2.14B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →